Author: Stephanie Richards
Publisher: Routledge
ISBN: 1134870736
Category : Psychology
Languages : en
Pages : 412
Book Description
Designed for clinicians from a variety of backgrounds, this handbook provides useful information regarding long-term treatment of neuropsychiatric disorders. It is intended not only for psychiatrists and neurologists, but also for primary care physicians and non-physician mental health professionals. The book examines maintenance treatment for a comprehensive list of mental illnesses including biopolar disorders, anxiety disorders, schizophrenia, and dementia. It provides the clinician with the information needed to select and manage the effective long-range treatment of their patients.
Maintenance Pharmacotherapies for Neuropsychiatric Disorders
Author: Stephanie Richards
Publisher: Routledge
ISBN: 1134870736
Category : Psychology
Languages : en
Pages : 412
Book Description
Designed for clinicians from a variety of backgrounds, this handbook provides useful information regarding long-term treatment of neuropsychiatric disorders. It is intended not only for psychiatrists and neurologists, but also for primary care physicians and non-physician mental health professionals. The book examines maintenance treatment for a comprehensive list of mental illnesses including biopolar disorders, anxiety disorders, schizophrenia, and dementia. It provides the clinician with the information needed to select and manage the effective long-range treatment of their patients.
Publisher: Routledge
ISBN: 1134870736
Category : Psychology
Languages : en
Pages : 412
Book Description
Designed for clinicians from a variety of backgrounds, this handbook provides useful information regarding long-term treatment of neuropsychiatric disorders. It is intended not only for psychiatrists and neurologists, but also for primary care physicians and non-physician mental health professionals. The book examines maintenance treatment for a comprehensive list of mental illnesses including biopolar disorders, anxiety disorders, schizophrenia, and dementia. It provides the clinician with the information needed to select and manage the effective long-range treatment of their patients.
Medications for Opioid Use Disorder Save Lives
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309486483
Category : Medical
Languages : en
Pages : 175
Book Description
The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.
Publisher: National Academies Press
ISBN: 0309486483
Category : Medical
Languages : en
Pages : 175
Book Description
The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.
Pharmacotherapy for Child and Adolescent Psychiatric Disorders
Author: David Rosenberg
Publisher: CRC Press
ISBN: 0824743857
Category : Medical
Languages : en
Pages : 713
Book Description
The Second Edition of Pharmacotherapy for Child and Adolescent Psychiatric Disorders contains new and expanded chapters on combination therapy pharmacoepidemiology pharmacoeconomics current social, ethical, and legal issues surrounding the administration of psychostimulants and antidepressants to children and teenagers serotonin reuptake inhibitors and discusses techniques to select the most appropriate drug and dosing schedule methods to adjust safely and tailor medical treatments for children during various stages of growth and development the effect of psychoactive drugs on cardiac function Offering nearly 3000 contemporary references to facilitate further research, Pharmacotherapy for Child and Adolescent Psychiatric Disorders, Second Edition is a timely and authoritative guide suitable for psychiatrists, psychologists, pediatricians, pharmaceutical and behavioral scientists, clinical neurologists, primary care physicians, social workers, and graduate and medical school students in these disciplines.
Publisher: CRC Press
ISBN: 0824743857
Category : Medical
Languages : en
Pages : 713
Book Description
The Second Edition of Pharmacotherapy for Child and Adolescent Psychiatric Disorders contains new and expanded chapters on combination therapy pharmacoepidemiology pharmacoeconomics current social, ethical, and legal issues surrounding the administration of psychostimulants and antidepressants to children and teenagers serotonin reuptake inhibitors and discusses techniques to select the most appropriate drug and dosing schedule methods to adjust safely and tailor medical treatments for children during various stages of growth and development the effect of psychoactive drugs on cardiac function Offering nearly 3000 contemporary references to facilitate further research, Pharmacotherapy for Child and Adolescent Psychiatric Disorders, Second Edition is a timely and authoritative guide suitable for psychiatrists, psychologists, pediatricians, pharmaceutical and behavioral scientists, clinical neurologists, primary care physicians, social workers, and graduate and medical school students in these disciplines.
Pharmacological Treatment of Mental Disorders in Primary Health Care
Author: World Health Organization
Publisher: World Health Organization
ISBN: 9241547693
Category : Medical
Languages : en
Pages : 80
Book Description
This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.
Publisher: World Health Organization
ISBN: 9241547693
Category : Medical
Languages : en
Pages : 80
Book Description
This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.
Psychiatric Nursing - E-Book
Author: Norman L. Keltner
Publisher: Elsevier Health Sciences
ISBN: 0323293522
Category : Medical
Languages : en
Pages : 550
Book Description
Learn the therapeutic skills you need to succeed in the nurse’s role in psychiatric care! Psychiatric Nursing, 7th Edition uses a practical approach to psychotherapeutic management that clearly explains how to manage and treat individuals with psychiatric disorders. It emphasizes the nurse’s three primary tools: you and your relationship with patients, medications, and the environment. This edition adds a new chapter on forensics along with coverage of the latest trends and treatments. Written by educators Norman Keltner and Debbie Steele, this text provides a solid, real-world foundation for the practice of safe and effective psychiatric nursing care. Unique! A practical, three-pronged approach to psychotherapeutic management includes: 1) the therapeutic nurse-patient relationship, 2) psychopharmacology, and 3) milieu management. Unique! Norm’s Notes offer helpful tips from the lead author, Norman Keltner, at the beginning of each chapter, making it easier to understand difficult topics. Nursing care plans highlight the nurse’s role in psychiatric care, emphasizing assessment, planning, nursing diagnoses, implementation, and evaluation for specific disorders. Case studies depict psychiatric disorders and show the development of effective nursing care strategies. Unique! Putting It All Together summaries are provided at the end of each psychopathology chapter. Clinical examples from the authors’ own experiences illustrate concepts with real-life clinical situations. Study Notes summarize each chapter’s important content. Learning objectives at the beginning of each chapter preview the important principles to follow. Critical thinking questions help you develop clinical reasoning skills. Family Issues boxes highlight the issues that families must confront when a member suffers from mental illness. Learning resources on the Evolve companion website include video lectures, psychotropic drug monographs, and NCLEX® exam-style review questions. Patient and Family Education boxes highlight information that the nurse should provide to patients and families. A glossary defines key terms, providing a handy reference at the back of the book. NEW! DSM-5 information is integrated throughout the text, along with updated content and NANDA content. NEW! Survivors of Violence and Trauma chapter focuses on psychiatric treatment for individuals with mental illness in sex trafficking and forensic environments, along with the social implications for individuals, families, and communities. NEW! Integration of QSEN competencies highlights the competencies relevant to psychiatric nursing care such as safety, communication, evidence-based practice and others. NEW! Additional NCLEX® examination-style review questions on the Evolve companion website cover concepts likely to appear on class tests and the NCLEX exam.
Publisher: Elsevier Health Sciences
ISBN: 0323293522
Category : Medical
Languages : en
Pages : 550
Book Description
Learn the therapeutic skills you need to succeed in the nurse’s role in psychiatric care! Psychiatric Nursing, 7th Edition uses a practical approach to psychotherapeutic management that clearly explains how to manage and treat individuals with psychiatric disorders. It emphasizes the nurse’s three primary tools: you and your relationship with patients, medications, and the environment. This edition adds a new chapter on forensics along with coverage of the latest trends and treatments. Written by educators Norman Keltner and Debbie Steele, this text provides a solid, real-world foundation for the practice of safe and effective psychiatric nursing care. Unique! A practical, three-pronged approach to psychotherapeutic management includes: 1) the therapeutic nurse-patient relationship, 2) psychopharmacology, and 3) milieu management. Unique! Norm’s Notes offer helpful tips from the lead author, Norman Keltner, at the beginning of each chapter, making it easier to understand difficult topics. Nursing care plans highlight the nurse’s role in psychiatric care, emphasizing assessment, planning, nursing diagnoses, implementation, and evaluation for specific disorders. Case studies depict psychiatric disorders and show the development of effective nursing care strategies. Unique! Putting It All Together summaries are provided at the end of each psychopathology chapter. Clinical examples from the authors’ own experiences illustrate concepts with real-life clinical situations. Study Notes summarize each chapter’s important content. Learning objectives at the beginning of each chapter preview the important principles to follow. Critical thinking questions help you develop clinical reasoning skills. Family Issues boxes highlight the issues that families must confront when a member suffers from mental illness. Learning resources on the Evolve companion website include video lectures, psychotropic drug monographs, and NCLEX® exam-style review questions. Patient and Family Education boxes highlight information that the nurse should provide to patients and families. A glossary defines key terms, providing a handy reference at the back of the book. NEW! DSM-5 information is integrated throughout the text, along with updated content and NANDA content. NEW! Survivors of Violence and Trauma chapter focuses on psychiatric treatment for individuals with mental illness in sex trafficking and forensic environments, along with the social implications for individuals, families, and communities. NEW! Integration of QSEN competencies highlights the competencies relevant to psychiatric nursing care such as safety, communication, evidence-based practice and others. NEW! Additional NCLEX® examination-style review questions on the Evolve companion website cover concepts likely to appear on class tests and the NCLEX exam.
Psychiatric Nursing
Author: Norman L. Keltner
Publisher: Elsevier Health Sciences
ISBN: 0323293514
Category : Medical
Languages : en
Pages : 563
Book Description
Learn the therapeutic skills you need for your role in psychiatric nursing care! Psychiatric Nursing uses a practical, three-pronged approach to psychotherapeutic management that clearly explains how to care for patients with psychiatric disorders. It emphasizes the nurse's three primary tools: themselves, medications, and the environment. Written by Norman L. Keltner, Carol E. Bostrom, and Teena McGuinness, each an educator and advanced practice nurse, this text covers the latest trends and treatments and provides a solid, real-world foundation for the practice of safe and effective psychiatric nursing care. Unique! A practical three-pronged approach to psychotherapeutic management includes: 1) the therapeutic nurse-patient relationship, 2) psychopharmacology, and 3) milieu management. Unique! Norm's Notes offer helpful tips from the lead author at the beginning of each chapter, making it easier to understand difficult topics. Unique! Putting It All Together summaries are provided at the end of each chapter. Patient and Family Education boxes highlight information that should be provided to patients and families. Family Issues boxes highlight the issues families must confront when a member suffers from mental illness. Nursing care plans emphasize assessment, planning, nursing diagnoses, implementation, and evaluation for specific disorders. Case studies depict psychiatric disorders and show the development of effective nursing care strategies. Clinical examples from the authors' own experiences illustrate concepts with real-life clinical situations. Learning objectives at the beginning of each chapter preview the important principles to follow. Study Notes summarize each chapter's important content. Critical thinking questions help you expand your clinical reasoning skills. Suicide and Other Self Destructive Behaviors chapter identifies risk factors associated with suicidality and various forms and characteristics of self-mutilation. War Related Psychiatric Disorders chapter describes the symptoms and treatment options for posttraumatic stress disorder and traumatic brain injury patients. New approach for Introduction to Milieu Management chapter recognizes the shift of the therapeutic environment from inpatient units to community settings, plus nurses' changing roles. New approach for Nutraceuticals and Mental Health chapter focuses on foods that provide health and medical benefits. Student resources on the companion Evolve website include downloadable audio chapter summaries, NCLEX® examination-style review questions, psychotropic drug monographs, and learning activities.
Publisher: Elsevier Health Sciences
ISBN: 0323293514
Category : Medical
Languages : en
Pages : 563
Book Description
Learn the therapeutic skills you need for your role in psychiatric nursing care! Psychiatric Nursing uses a practical, three-pronged approach to psychotherapeutic management that clearly explains how to care for patients with psychiatric disorders. It emphasizes the nurse's three primary tools: themselves, medications, and the environment. Written by Norman L. Keltner, Carol E. Bostrom, and Teena McGuinness, each an educator and advanced practice nurse, this text covers the latest trends and treatments and provides a solid, real-world foundation for the practice of safe and effective psychiatric nursing care. Unique! A practical three-pronged approach to psychotherapeutic management includes: 1) the therapeutic nurse-patient relationship, 2) psychopharmacology, and 3) milieu management. Unique! Norm's Notes offer helpful tips from the lead author at the beginning of each chapter, making it easier to understand difficult topics. Unique! Putting It All Together summaries are provided at the end of each chapter. Patient and Family Education boxes highlight information that should be provided to patients and families. Family Issues boxes highlight the issues families must confront when a member suffers from mental illness. Nursing care plans emphasize assessment, planning, nursing diagnoses, implementation, and evaluation for specific disorders. Case studies depict psychiatric disorders and show the development of effective nursing care strategies. Clinical examples from the authors' own experiences illustrate concepts with real-life clinical situations. Learning objectives at the beginning of each chapter preview the important principles to follow. Study Notes summarize each chapter's important content. Critical thinking questions help you expand your clinical reasoning skills. Suicide and Other Self Destructive Behaviors chapter identifies risk factors associated with suicidality and various forms and characteristics of self-mutilation. War Related Psychiatric Disorders chapter describes the symptoms and treatment options for posttraumatic stress disorder and traumatic brain injury patients. New approach for Introduction to Milieu Management chapter recognizes the shift of the therapeutic environment from inpatient units to community settings, plus nurses' changing roles. New approach for Nutraceuticals and Mental Health chapter focuses on foods that provide health and medical benefits. Student resources on the companion Evolve website include downloadable audio chapter summaries, NCLEX® examination-style review questions, psychotropic drug monographs, and learning activities.
Anxiety and Substance Use Disorders
Author: Sherry H. Stewart
Publisher: Springer Science & Business Media
ISBN: 0387742905
Category : Psychology
Languages : en
Pages : 280
Book Description
Disorders of anxiety and substance use are, for some reason, rarely treated in an integrated fashion by professionals. This timely volume addresses this glaring omission with dispatches from the frontlines of research and treatment. Thirty-four international experts offer findings, theories, and intervention strategies for this common form of dual disorder, across a range of substances and of anxiety disorders, to give the reader comprehensive knowledge in a practical format.
Publisher: Springer Science & Business Media
ISBN: 0387742905
Category : Psychology
Languages : en
Pages : 280
Book Description
Disorders of anxiety and substance use are, for some reason, rarely treated in an integrated fashion by professionals. This timely volume addresses this glaring omission with dispatches from the frontlines of research and treatment. Thirty-four international experts offer findings, theories, and intervention strategies for this common form of dual disorder, across a range of substances and of anxiety disorders, to give the reader comprehensive knowledge in a practical format.
Ending Discrimination Against People with Mental and Substance Use Disorders
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309439124
Category : Social Science
Languages : en
Pages : 171
Book Description
Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.
Publisher: National Academies Press
ISBN: 0309439124
Category : Social Science
Languages : en
Pages : 171
Book Description
Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.
Psychotropic Drugs
Author: Norman L. Keltner
Publisher: Mosby
ISBN:
Category : Medical
Languages : en
Pages : 800
Book Description
New medications include aripiprazole, atomoxetine, duloxetine, escitalopram, galantamine, lamotrigine (i.e., its newer indications), and memantine."--BOOK JACKET.
Publisher: Mosby
ISBN:
Category : Medical
Languages : en
Pages : 800
Book Description
New medications include aripiprazole, atomoxetine, duloxetine, escitalopram, galantamine, lamotrigine (i.e., its newer indications), and memantine."--BOOK JACKET.
The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder
Author: American Psychiatric Association
Publisher: American Psychiatric Pub
ISBN: 0890426821
Category : Medical
Languages : en
Pages : 226
Book Description
Alcohol use disorder (AUD) is a major public health problem in the United States. The estimated 12-month and lifetime prevalence values for AUD are 13.9% and 29.1%, respectively, with approximately half of individuals with lifetime AUD having a severe disorder. AUD and its sequelae also account for significant excess mortality and cost the United States more than $200 billion annually. Despite its high prevalence and numerous negative consequences, AUD remains undertreated. In fact, fewer than 1 in 10 individuals in the United States with a 12-month diagnosis of AUD receive any treatment. Nevertheless, effective and evidence-based interventions are available, and treatment is associated with reductions in the risk of relapse and AUD-associated mortality. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individuals. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD. In addition to reviewing the available evidence on the use of AUD pharmacotherapy, the guideline offers clear, concise, and actionable recommendation statements, each of which is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. The guideline provides guidance on implementing these recommendations into clinical practice, with the goal of improving quality of care and treatment outcomes of AUD.
Publisher: American Psychiatric Pub
ISBN: 0890426821
Category : Medical
Languages : en
Pages : 226
Book Description
Alcohol use disorder (AUD) is a major public health problem in the United States. The estimated 12-month and lifetime prevalence values for AUD are 13.9% and 29.1%, respectively, with approximately half of individuals with lifetime AUD having a severe disorder. AUD and its sequelae also account for significant excess mortality and cost the United States more than $200 billion annually. Despite its high prevalence and numerous negative consequences, AUD remains undertreated. In fact, fewer than 1 in 10 individuals in the United States with a 12-month diagnosis of AUD receive any treatment. Nevertheless, effective and evidence-based interventions are available, and treatment is associated with reductions in the risk of relapse and AUD-associated mortality. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individuals. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD. In addition to reviewing the available evidence on the use of AUD pharmacotherapy, the guideline offers clear, concise, and actionable recommendation statements, each of which is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. The guideline provides guidance on implementing these recommendations into clinical practice, with the goal of improving quality of care and treatment outcomes of AUD.